Inventor · disambiguated record
Stephane Peluso
Also filed as: PELUSO STEPHANE
26 granted patents·8 pending applications·243 citations·filing 2006–2020
96Inventor score
Files withMILLENNIUM PHARM INC11INFINITY PHARMACEUTICALS INC10CASTRO ALFREDO C4BEHNKE MARK L3AUSTAD BRIAN2
Top patents by PatentIndex Score
34 records- 0199US7812164B2Cyclopamine analogsINFINITY PHARMACEUTICALS INC·Filed 2007·Granted Oct 12, 2010·84 cites·2 claims
- 0297US8008307B2Heteroaryl compounds useful as inhibitors of E1 activating enzymesMILLENNIUM PHARM INC·Filed 2007·Granted Aug 30, 2011·25 cites·17 claims
- 0395US10406139B2Cyclopamine analogsINFINITY PHARMACEUTICALS INC·Filed 2018·Granted Sep 10, 2019·8 cites·5 claims
- 0495US8481550B2Heteroaryl compounds useful as inhibitors of E1 activating enzymesCLAIBORNE CHRISTOPHER F·Filed 2011·Granted Jul 9, 2013·19 cites·14 claims
- 0594US9492435B2Cyclopamine analogsINFINITY PHARMACEUTICALS INC·Filed 2014·Granted Nov 15, 2016·13 cites·15 claims
- 0694US9150525B2Heteroaryl compounds useful as inhibitors of E1 activating enzymesMILLENNIUM PHARM INC·Filed 2014·Granted Oct 6, 2015·10 cites·19 claims
- 0794US8785635B2Cyclopamine analogsAUSTAD BRIAN·Filed 2008·Granted Jul 22, 2014·16 cites·38 claims
- 0894US8669365B2Cyclopamine analogsAUSTAD BRIAN·Filed 2008·Granted Mar 11, 2014·21 cites·25 claims
- 0993US8901136B2Heteroaryl compounds useful as inhibitors of E1 activating enzymesMILLENNIUM PHARM INC·Filed 2013·Granted Dec 2, 2014·12 cites·9 claims
- 1092US7951810B2Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of E1 activating enzymesMILLENNIUM PHARM INC·Filed 2006·Granted May 31, 2011·16 cites·19 claims
- 1190US11007181B2Cyclopamine analogsINFINITY PHARMACEUTICALS INC·Filed 2019·Granted May 18, 2021·1 cites·2 claims
- 1290US9951083B2Cyclopamine analogsINFINITY PHARMACEUTICALS INC·Filed 2016·Granted Apr 24, 2018·4 cites·19 claims
- 1388US9458108B2Heteroaryl compounds useful as inhibitors of E1 activating enzymesMILLENNIUM PHARM INC·Filed 2015·Granted Oct 4, 2016·3 cites·18 claims
- 1481US8546432B2Tetrazolones as inhibitors of fatty acid synthaseBAHADOOR ADILAH·Filed 2011·Granted Oct 1, 2013·7 cites·35 claims
- 1575US9346769B2Tetrazolones as inhibitors of fatty acid synthaseINFINITY PHARMACEUTICALS INC·Filed 2013·Granted May 24, 2016·2 cites·57 claims
- 1670US2021070798A1Inhibitors of E1 activating enzymesMILLENNIUM PHARM INC·Filed 2020·Application pending·0 cites
- 1768US8765735B2Isoxazolines as inhibitors of fatty acid amide hydrolaseBEHNKE MARK L·Filed 2010·Granted Jul 1, 2014·1 cites·30 claims
- 1867US9718788B2Heteroaryl compounds useful as inhibitors of E1 activating enzymesMILLENNIUM PHARM INC·Filed 2016·Granted Aug 1, 2017·0 cites·1 claims
- 1966US8450350B2Triazoles as inhibitors of fatty acid synthaseBAHADOOR ADILAH·Filed 2011·Granted May 28, 2013·1 cites·37 claims
- 2066US2017073367A9Substituted pyrrolo[2,3-d]pyrimidinesMILLENNIUM PHARM INC·Filed 2014·Application pending·0 cites
- 2162US2014256668A9Substituted pyrrolo]2,3-d]pyrimidinesMILLENNIUM PHARM INC·Filed 2013·Application pending·0 cites
- 2262US2018086785A1Substituted pyrrolo[2,3-d]pyrimidinesMILLENNIUM PHARM INC·Filed 2017·Application pending·0 cites
- 2359US7928244B2Compounds and methods for inhibiting the interaction of BCL proteins with binding partnersINFINITY DISCOVERY INC·Filed 2007·Granted Apr 19, 2011·0 cites·37 claims
- 2457US2011136834A1Inhibitors of e1 activating enzymesMILLENNIUM PHARM INC·Filed 2011·Application pending·0 cites
- 2556US8178690B2Compounds and methods for inhibiting the interaction of BCL proteins with binding partnersCASTRO ALFREDO C·Filed 2011·Granted May 15, 2012·0 cites·15 claims
- 2654US8609706B2Compounds and methods for inhibiting the interaction of BCL proteins with binding partnersCASTRO ALFREDO C·Filed 2012·Granted Dec 17, 2013·0 cites·14 claims
- 2754US7745464B2Compounds and methods for inhibiting the interaction of BCL proteins with binding partnersCASTRO ALFREDO C·Filed 2006·Granted Jun 29, 2010·0 cites·18 claims
- 2853US2015099738A1Isoxazolines as inhibitors of fatty acid amide hydrolaseINFINITY PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2950US9630979B2Inhibitors of monoacylglycerol lipase and methods of their useINFINITY PHARMACEUTICALS INC·Filed 2012·Granted Apr 25, 2017·0 cites·22 claims
- 3049US2013243727A1Triazoles as inhibitors of fatty acid synthaseINFINITY PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3149US2017119734A1Tetrazolones as inhibitors of fatty acid synthaseINFINITY PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3244US8304428B2Compounds and methods for inhibiting the interaction of BCL proteins with binding partnersCASTRO ALFREDO C·Filed 2010·Granted Nov 6, 2012·0 cites·41 claims
- 3343US9149465B2Isoxazolines as inhibitors of fatty acid amide hydrolaseBEHNKE MARK L·Filed 2010·Granted Oct 6, 2015·0 cites·10 claims
- 3434US8927551B2Isoxazolines as inhibitors of fatty acid amide hydrolaseBEHNKE MARK L·Filed 2010·Granted Jan 6, 2015·0 cites·45 claims
Join the waitlist — get patent alerts
Get an alert when Stephane Peluso files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →